The electronic tongue used by Pascual in prostate cancer patients distinguished cases from controls with a sensitivity of 91% and a specificity of 73% [29], which is even higher than the prostate-specific antigen (PSA) test in blood. This evidence concerns the gene KLK3 and prostate carcinoma.